In this study, we found that BARD1 and BRCA1 were highly expressed in tamoxifen-resistant breast cancer cells, which led to enhanced DNA damage repair and resistance to DNA-damaging chemotherapy. The gene discussed is BRCA1; the disease is breast carcinoma.